CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY
Clinical trials for CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY explained in plain language.
Never miss a new study
Get alerted when new CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY trials appear
Sign up with your email to follow new studies for CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Simple gloves may shield breast cancer patients from chemo nerve pain
Symptom relief OngoingThis study tests whether wearing surgical gloves during paclitaxel chemotherapy can prevent nerve damage (peripheral neuropathy) in breast cancer patients. About 104 people with stage II-III breast cancer will be randomly assigned to wear gloves or not. Researchers will compare c…
Matched conditions: CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY
Phase: NA • Sponsor: Young-Joon Kang • Aim: Symptom relief
Last updated May 17, 2026 00:51 UTC
-
Exercise may ease chemo nerve pain in new trial
Symptom relief OngoingThis study looks at whether exercise can reduce symptoms of chemotherapy-induced peripheral neuropathy (CIPN), such as pain, numbness, and tingling in the hands and feet. About 133 cancer patients who have nerve damage from chemo will either do an exercise program or receive usua…
Matched conditions: CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY
Phase: NA • Sponsor: University of Rochester NCORP Research Base • Aim: Symptom relief
Last updated May 17, 2026 00:49 UTC
-
Can a nutraceutical soothe chemo nerve damage?
Symptom relief OngoingThis study tests whether a natural supplement called PEA can relieve nerve pain, numbness, and tingling caused by chemotherapy in cancer patients. About 88 adults who have had these symptoms for at least 3 months will take PEA or a placebo for 8 weeks. The goal is to see if PEA i…
Matched conditions: CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY
Phase: PHASE2 • Sponsor: Academic and Community Cancer Research United • Aim: Symptom relief
Last updated May 14, 2026 12:06 UTC
-
Home workouts may ease chemo nerve damage
Symptom relief OngoingThis early study tests whether a 10-week home exercise program is safe and helpful for cancer survivors who have lasting nerve pain, numbness, or tingling from chemotherapy. About 40 people will take part, doing remote exercise sessions and health coaching calls. The main goal is…
Matched conditions: CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY
Phase: PHASE1 • Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated May 12, 2026 13:43 UTC
-
Yoga vs. nerve pain: major trial tests Drug-Free relief for cancer survivors
Symptom relief OngoingThis study tests whether yoga can reduce nerve pain (peripheral neuropathy) caused by chemotherapy. About 227 cancer survivors will either take yoga classes, attend educational sessions, or continue their usual care. Researchers will measure pain levels, balance, fall risk, and q…
Matched conditions: CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Symptom relief
Last updated May 12, 2026 13:40 UTC
-
Can acupuncture ease Chemo's lingering nerve pain?
Symptom relief OngoingThis study tests whether electroacupuncture (a type of acupuncture with mild electric pulses) can reduce nerve pain caused by chemotherapy in cancer survivors. About 255 people who have finished chemo and still have pain, numbness, or tingling in their hands or feet will receive …
Matched conditions: CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Symptom relief
Last updated May 06, 2026 16:02 UTC
-
Can a natural nerve protector stop chemo's painful side effects?
Symptom relief TerminatedThis trial is testing whether a substance called GM1 can prevent or reduce nerve damage caused by paclitaxel chemotherapy. The study involves about 100 people with metastatic breast cancer who are receiving paclitaxel treatment. Researchers want to see if giving GM1 alongside che…
Matched conditions: CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY
Phase: PHASE2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Symptom relief
Last updated Apr 22, 2026 15:58 UTC